Janssen wins FDA nod for Stelara to treat active psoriatic arthritis in children
The US health regulator approved Stelara as the first and only biologic targeting both cytokines interleukin (IL)-12 and…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
02 Aug 22
The US health regulator approved Stelara as the first and only biologic targeting both cytokines interleukin (IL)-12 and…
02 Aug 22
The new strategic collaboration will leverage Sosei Heptares’ StaR technology and SBDD platform and AbbVie’s extensive neuroscience expertise,…
01 Aug 22
The EC approval is supported by data from the Phase 3 SELECT-AXIS 2 clinical trial, in which Rinvoq…
01 Aug 22
Under the new agreement with the US government, the biotechnology company will receive up to $1.74bn for 66…
29 Jul 22
The acquisition will complement BD’s technology pharmacy solutions and further advance its smart, customisable, connected care platform to…
PharmaceuticalsHealthcare ITPharmaceutical Compliance Software
29 Jul 22
The current agreement builds on an existing partnership between ViiV Healthcare and MPP, where the two have manufactured…
28 Jul 22
Benlysta was previously approved in the US to treat active lupus nephritis in adult patients, and the current…
28 Jul 22
The Phase 2 trial of BNT162b5 will enrol around 200 participants, aged between 18 and 55 years, who…
27 Jul 22
The EC approved Rinvoq based on positive data from induction studies, U-ACHIEVE induction and U-ACCOMPLISH, and a maintenance…
27 Jul 22
The expanded approval for Nuvaxovid in Japan and Australia is supported by positive safety, immunogenicity, and efficacy data…